Not finding it? Sign in to also search OpenAlex live.
-
Utilizing rat kidney gene co-expression networks to enhance safety assessment biomarker identification and human translation2025 iScience article Biochemistry, Genetics and Molecular Biology Bioinformatics and Genomic Networks Open access
Steven J. Kunnen, Giulia Callegaro, Jeffrey J. Sutherland, Panuwat Trairatphisan, Hugo W van Kessel, Lukas S. Wijaya, +11 more
7citations -
Utilizing gene co-expression networks with the rat kidney TXG-MAPr tool to enhance safety assessment, biomarker identification and human translation2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Bioinformatics and Genomic Networks Open access
Steven J. Kunnen, Giulia Callegaro, Jeffrey J. Sutherland, Panuwat Trairatphisan, Hugo W van Kessel, Lukas S. Wijaya, +11 more
1citations -
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases – a systematic literature review informing the 2024 update of an international expert consensus statement2025 Annals of the Rheumatic Diseases review Medicine Rheumatoid Arthritis Research and Therapies Open access
Victoria Konzett, Josef S Smolen, Peter T. Nash, Kevin L. Winthrop, Daniel Aletaha, Thomas Dörner, +10 more
23citations -
Efficacy, Safety, and Quality of Life of Pegcetacoplan in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria Treated within the Phase 3 PEGASUS Trial2024 Acta Haematologica article Immunology and Microbiology Complement system in diseases Open access
Hisakazu Nishimori, Hideyuki Nakazawa, Shinobu Tamura, Toshiki Uchida, Kensuke Usuki, Johan Szamosi, +3 more
4citations -
Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups2021 Annals of Internal Medicine article Medicine Venous Thromboembolism Diagnosis and Management Open access
Milou A.M. Stals, Toshihiko Takada, Noémie Kraaijpoel, Nick van Es, Harry Roger Buller, Daniel Mark Courtney, +17 more
86citations -
Overall survival and long-term safety in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: Updated analyses from INTRIGUE.2023 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
Robin L. Jones, Jean‐Yves Blay, Suzanne George, Hans A. J. Gelderblom, Patrick Schöffski, Margaret von Mehren, +12 more
1citations -
POS0788 BIMEKIZUMAB DEMONSTRATED SUSTAINED EFFICACY AND SAFETY ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM TWO PHASE 3 STUDIES AND THEIR OPEN-LABEL EXTENSION2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
X. Baraliakos, A. Deodhar, Désirée M F M van der Heijde, Filip E Van den Bosch, M. Magrey, Walter P. Maksymowych, +6 more
1citations -
LY13 A confirmatory phase III multicentre, randomized, double-blind, placebo-controlled study of the efficacy of topical HyBryte™ (hypericin sodium) and visible-light activation for the treatment of cutaneous T-cell lymphoma: interim analysis results of primary efficacy and safety for FLASH22026 British Journal of Dermatology conference-abstract Medicine Cutaneous lymphoproliferative disorders research
Julia Jane Scarisbrick, Maarten H. Vermeer, Martine Bagot, Pablo Ortiz‐Romero, Pietro Quaglino, Ellen J. Kim, +1 more
0citations -
Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial
Antonio Maria Risitano, Austin Gladston Kulasekararaj, Alexander Roeth, Phillip Scheinberg, Yutaka Ueda, Eros Di Bona, +29 more
14citations -
O09 Long-term safety of ustekinumab in paediatric patients with moderate-to-severe plaque psoriasis: results from an ongoing observational study2023 British Journal of Dermatology conference-abstract Immunology and Microbiology Psoriasis: Treatment and Pathogenesis
Emmanuel Mahé, Anja B. Geldhof, Evgenia Movshovich, Sandra Malynn, Michela Efficace, Marieke M.B. Seyger
1citations -
OR03-07 Real-World Effectiveness and Safety of Recombinant Human IGF-1 Treatment in Naïve Prepubertal Patients with Severe Primary IGF-I Deficiency at Near-Adult Height: Results from the Global IGFD Registry2025 Journal of the Endocrine Society article Medicine Growth Hormone and Insulin-like Growth Factors Open access
Philippe Ferdinand Backeljauw, Jesús Argente, Artur Tadeusz Bossowski, Jean De Schepper, Mohamad Maghnie, Michel Polak, +5 more
0citations -
Phase III Randomized COMMODORE 1 Trial: 2-Year Safety and Efficacy of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Switched from Eculizumab2024 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Phillip Scheinberg, Diego V. Clé, Bérangère Devalet, Valentina Giai, Cristina Barrenetxea Lekue, Hsuan‐Yu Lin, +12 more
0citations -
ABS0815 EFFICACY AND SAFETY OF TOFACITINIB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS NAÏve TO BIOLOGIC OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
James Benjamin Galloway, Sofía Ramiro, Lídia Sànchez-Riera, Mary Jane Cadatal, M. Montoro
0citations -
Long-term safety and efficacy of iptacopan in patients with paroxysmal nocturnal hemoglobinuria: 4- and 5-year follow-up of patients from Phase 2 studies who entered the roll-over extension program
Antonio Maria Risitano, Camilla Frieri, Bor‐Sheng Ko, Lily Wong Lee Lee, Alexander Röth, Flore Sicre de Fontbrune, +8 more
0citations -
OA12 An update on the integrated safety analysis of filgotinib in patients with moderate to severe active rheumatoid arthritis over a median of 4.3 years2025 Rheumatology conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Kevin L. Winthrop, Daniel Aletaha, Roberto Felice Caporali, Yoshiya Tanaka, Tsutomu Takeuchi, Maya H Buch, +6 more
0citations -
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study2024 Advances in Therapy article Immunology and Microbiology Complement system in diseases Open access
Christopher Jordan Patriquin, Andrija D. Bogdanovic, Morag Griffin, Richard J. Kelly, Jaroslaw Pawel Maciejewski, Brian Patrick Mulherin, +9 more
20citations -
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe2024 Pharmacoepidemiology and Drug Safety article Computer Science Research Data Management Practices Open access
Rosa Gini, Romin Pajouheshnia, Lia Gutiérrez, Morris A. Swertz, Eleanor Hyde, Miriam Sturkenboom, +40 more
2citations -
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe2024 Pharmacoepidemiology and Drug Safety article Computer Science Research Data Management Practices Open access
Romin Pajouheshnia, Rosa Gini, Lia Gutiérrez, Morris A. Swertz, Eleanor Hyde, Miriam Sturkenboom, +40 more
10citations -
Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studies2023 Pharmacoepidemiology and Drug Safety article Mathematics Statistical Methods in Clinical Trials Open access
Kim Luijken, Rik van EEKELEN, Helga Gardarsdóttir, Rolf H. H. Groenwold, Nan van Geloven
21citations -
Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis2022 Arthritis Care & Research article Medicine Systemic Lupus Erythematosus Research Open access cited by 1 patent
Cristina Arriens, Y K Onno Teng, Ellen M. Ginzler, Samir V. Parikh, Anca Askanase, Amit Saxena, +8 more
46citations